- Home
- CMMB vs EBON Comparison
CMMB vs EBON Comparison
Compare CMMB & EBON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- EBON
- Stock Information
- Founded
- CMMB 2004
- EBON 2010
- Country
- CMMB Israel
- EBON China
- Employees
- CMMB N/A
- EBON N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- EBON Semiconductors
- Sector
- CMMB Health Care
- EBON Technology
- Exchange
- CMMB Nasdaq
- EBON Nasdaq
- Market Cap
- CMMB 23.0M
- EBON 21.2M
- IPO Year
- CMMB N/A
- EBON 2020
- Fundamental
- Price
- CMMB $1.21
- EBON $4.16
- Analyst Decision
- CMMB Strong Buy
- EBON
- Analyst Count
- CMMB 2
- EBON 0
- Target Price
- CMMB $9.00
- EBON N/A
- AVG Volume (30 Days)
- CMMB 89.3K
- EBON 8.1K
- Earning Date
- CMMB 05-27-2025
- EBON 04-28-2025
- Dividend Yield
- CMMB N/A
- EBON N/A
- EPS Growth
- CMMB N/A
- EBON N/A
- EPS
- CMMB N/A
- EBON N/A
- Revenue
- CMMB N/A
- EBON $5,868,771.00
- Revenue This Year
- CMMB N/A
- EBON N/A
- Revenue Next Year
- CMMB N/A
- EBON N/A
- P/E Ratio
- CMMB N/A
- EBON N/A
- Revenue Growth
- CMMB N/A
- EBON 20.88
- 52 Week Low
- CMMB $0.60
- EBON $3.00
- 52 Week High
- CMMB $2.55
- EBON $10.94
- Technical
- Relative Strength Index (RSI)
- CMMB 46.51
- EBON 59.39
- Support Level
- CMMB $1.15
- EBON $3.42
- Resistance Level
- CMMB $1.31
- EBON $4.56
- Average True Range (ATR)
- CMMB 0.09
- EBON 0.23
- MACD
- CMMB -0.00
- EBON 0.12
- Stochastic Oscillator
- CMMB 22.58
- EBON 64.89
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services. Its geographic regions are Mainland China, Australia, and Other countries and regions.